Fluoro-edenite induces fibulin-3 overexpression in non-malignant human mesothelial cells

Rapisarda,Venerando; Salemi,Rossella; Marconi,Andrea; Loreto,Carla; Graziano,Adriana  C.; Cardile,Venera; Basile,Maria  S.; Candido,Saverio; Falzone,Luca; Spandidos,Demetrios  A.; Fenga,Concettina; Libra,Massimo

doi:10.3892/ol.2016.5051

Fluoro-edenite induces fibulin-3 overexpression in non-malignant human mesothelial cells

Authors:
- Venerando Rapisarda
- Rossella Salemi
- Andrea Marconi
- Carla Loreto
- Adriana C. Graziano
- Venera Cardile
- Maria S. Basile
- Saverio Candido
- Luca Falzone
- Demetrios A. Spandidos
- Concettina Fenga
- Massimo Libra
View Affiliations

Affiliations: Section of Occupational Medicine, Department of Clinical and Experimental Medicine, University of Catania, I-95124 Catania, Italy, Section of General and Clinical Pathology and Oncology, Department of Biomedical and Biotechnological Sciences, University of Catania, I-95124 Catania, Italy, Section of Human Anatomy and Histology, Department of Biomedical and Biotechnological Sciences, University of Catania, I-95124 Catania, Italy, Section of Physiology, Department of Biomedical and Biotechnological Sciences, University of Catania, I-95124 Catania, Italy, Department of Virology, Faculty of Medicine, University of Crete, 71003 Heraklion, Crete, Greece, Section of Occupational Medicine, Department of the Environment, Safety, Territory, Food and Health Sciences, University of Messina, I-98125 Messina, Italy
Published online on: August 26, 2016 https://doi.org/10.3892/ol.2016.5051
Pages: 3363-3367
Copyright: © Rapisarda et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Exposure to asbestos is associated with the development of mesothelioma. In addition to asbestos, other fibers have been identified as risk factors for malignant and non-malignant diseases of the lungs. Among these, fluoro-edenite (FE) was found in patients from Biancavilla (Sicily, Italy) with pleural and lung disease, suggesting its role for tumor expansion. In this context, the identification of early biomarkers useful for the diagnosis of cancer is mandatory. Fibulin-3 represents an important marker for the diagnosis of mesothelioma. However, it remains to be determined whether it is directly associated with exposure to asbestos-like fibers. In the present study, peripheral blood levels of fibulin-3 from 40 asbestos-exposed workers were compared with those detected in 27 street cleaners from Biancavilla. Intriguingly, the results showed that fibulin-3 levels were higher in the group of street cleaners compared with those of the asbestos-exposed workers, suggesting that these workers used the personal protective equipment according to the current regulations. These data suggest that subjects exposed to FE should be monitored for the risk of mesothelioma. FE and volcanic particulates are probably contained within dust inhaled by street cleaners from Biancavilla during their work activities. Based on these criteria, in this study, such fibers were used to treat mesothelial cells (MeT5A) in order to verify whether fibulin-3 levels are affected by these treatments. The results showed that only treatment with FE was associated with fibulin-3 overexpression at both the transcript and protein levels. It was previously demonstrated that mesothelial cells exhibited low levels of p27 following treatment with FE. Notably, p27 downregulation is associated with stathmin upregulation in cancer, conferring an aggressive phenotype of tumor cells. This observation prompted us to perform a computational evaluation demonstrating the activation of stathmin in lung cancer in patients exposed to asbestos. Overall, it can be speculated that both fibulin-3 and stathmin overexpression may be associated with the malignant transformation of mesothelial cells following exposure to asbestos-like fibers.

View Figures

View References

1	Wagner JC, Sleggs CA and Marchand P: Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br J Ind Med. 17:260–271. 1960.PubMed/NCBI
2	Boffetta P: Health effects of asbestos exposure in humans: a quantitative assessment. Med Lav. 89:471–480. 1998.PubMed/NCBI
3	International Agency for Research on Cancer, . Asbestos (Chrysolite, Amosite, Crocidolite, Tremolite, Actinolite, and Anthophyllite)IARC Monographs. Arsenic, Metals, Fibres and Dusts. International Agency for Research on Cancer; Lyon: pp. 147–167. 2009
4	Tan C and Treasure T: Mesothelioma: time to take stock. J R Soc Med. 98:455–458. 2005. View Article : Google Scholar : PubMed/NCBI
5	Robinson BW and Lake RA: Advances in malignant mesothelioma. N Engl J Med. 353:1591–1603. 2005. View Article : Google Scholar : PubMed/NCBI
6	McDonald JC and McDonald AD: The epidemiology of mesothelioma in historical context. Eur Respir J. 9:1932–1942. 1996. View Article : Google Scholar : PubMed/NCBI
7	Crisstaudo A, Foddis R and Guglielmi G: Methodology and results of an experience of medical surveillance of people previously exposed to asbestos in Tuscany. G Ital Med Lav Ergon. 32(Suppl 4): 385–388. 2010.(In Italian). PubMed/NCBI
8	Marcus PM, Bergstralh EJ, Fagerstrom RM, Williams DE, Fontana R, Taylor WF and Prorok PC: Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up. J Natl Cancer Inst. 92:1308–1316. 2000. View Article : Google Scholar : PubMed/NCBI
9	Loreto C, Rapisarda V, Carnazza ML, Musumeci G, Valentino M, Fenga C and Martinez G: Fluoro-edenite fibres induce lung cell apoptosis: an in vivo study. Histol Histopathol. 23:319–326. 2008.PubMed/NCBI
10	Pass HI, Levin SM, Harbut MR, Melamed J, Chiriboga L, Donington J, Huflejt M, Carbone M, Chia D, Goodglick L, et al: Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma. N Engl J Med. 367:1417–1427. 2012. View Article : Google Scholar : PubMed/NCBI
11	Rapisarda V, Ledda C, Migliore M, Salemi R, Musumeci A, Bracci M, Marconi A, Loreto C and Libra M: FBLN-3 as a biomarker of pleural plaques in workers occupationally exposed to carcinogenic fibers: a pilot study. Future Oncol. 11(Suppl 24): 35–37. 2015. View Article : Google Scholar : PubMed/NCBI
12	Bruni BM, Pacella A, MazziottiTagliani S, Gianfagna A and Paoletti L: Nature and extent of the exposure to fibrous amphiboles in Biancavilla. Sci Total Environ. 370:9–16. 2006. View Article : Google Scholar : PubMed/NCBI
13	Putzu MG, Bruno C, Zona A, Massiccio M, Pasetto R, Piolatto PG and Comba P: Fluoro-edenitic fibres in the sputum of subjects from Biancavilla (Sicily): a pilot study. Environ Health. 5:202006. View Article : Google Scholar : PubMed/NCBI
14	Ledda C, Rapisarda V, Bracci M, Proietti L, Zuccarello M, Fallico R, Fiore M and Ferrante M: Professional exposure to basaltic rock dust: assessment by the Vibrio fischeri ecotoxicological test. J Occup Med Toxicol. 8:232013. View Article : Google Scholar : PubMed/NCBI
15	Wright CM, Francis SM Savarimuthu, Tan ME, Martins MU, Winterford C, Davidson MR, Duhig EE, Clarke BE, Hayward NK, Yang IA, et al: MS4A1 dysregulation in asbestos-related lung squamous cell carcinoma is due to CD20 stromal lymphocyte expression. PLoS One. 7:e349432012. View Article : Google Scholar : PubMed/NCBI
16	Polesel J, Franceschi S, Talamini R, Negri E, Barzan L, Montella M, Libra M, Vaccher E, Franchin G, La Vecchia C and Serraino D: Tobacco smoking, alcohol drinking, and the risk of different histological types of nasopharyngeal cancer in a low-risk population. Oral Oncol. 47:541–545. 2011. View Article : Google Scholar : PubMed/NCBI
17	De Nardo P: More attention to veterinarian epidemiologists. Epidemiol Prev. 28:1942004.(In Italian). PubMed/NCBI
18	Paoletti L, Batisti D, Bruno C, Di Paola M, Gianfagna A, Mastrantonio M, Nesti M and Comba P: Unusually high incidence of malignant pleural mesothelioma in a town of eastern Sicily: an epidemiological and environmental study. Arch Environ Health. 55:392–398. 2000. View Article : Google Scholar : PubMed/NCBI
19	International Agency for Research on Cancer, . IARC Monographs on the evaluation of carcinogenic risks to humans. Supplement 7:1-42. IARC Press; Lyon: 1987
20	Committee on Asbestos: Selected Health Effects; Board on Population Health and Public Health Practices; Institute of Medicine, . Asbestos: Selected Cancers. The National Academies Press; Washington, DC: 2006
21	Goldberg M and Luce D: The health impact of nonoccupational exposure to asbestos: what do we know? Eur J Cancer Prev. 18:489–503. 2009. View Article : Google Scholar : PubMed/NCBI
22	Cardile V, Lombardo L, Belluso E, Panico A, Renis M, Gianfagna A and Balazy M: Fluoro-edenite fibers induce expression of Hsp70 and inflammatory response. Int J Environ Res Public Health. 4:195–202. 2007. View Article : Google Scholar : PubMed/NCBI
23	Musumeci G, Cardile V, Fenga C, Caggia S and Loreto C: Mineral fibre toxicity: Expression of retinoblastoma (Rb) and phospho-retinoblastoma (pRb) protein in alveolar epithelial and mesothelial cell lines exposed to fluoro-edenite fibres. Cell Biol Toxicol. 27:217–225. 2011. View Article : Google Scholar : PubMed/NCBI
24	Chu IM, Hengst L and Slingerland JM: The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy. Nat Rev Cancer. 8:253–267. 2008. View Article : Google Scholar : PubMed/NCBI
25	Baldassarre G, Belletti B, Nicoloso MS, Schiappacassi M, Vecchione A, Spessotto P, Morrione A, Canzonieri V and Colombatti A: p27(Kip1)-stathmin interaction influences sarcoma cell migration and invasion. Cancer Cell. 7:51–63. 2005. View Article : Google Scholar : PubMed/NCBI
26	Sonego M, Schiappacassi M, Lovisa S, Dall'Acqua A, Bagnoli M, Lovat F, Libra M, D'Andrea S, Canzonieri V, Militello L, et al: Stathmin regulates mutant p53 stability and transcriptional activity in ovarian cancer. EMBO Mol Med. 5:707–722. 2013. View Article : Google Scholar : PubMed/NCBI
27	McCubrey JA, Abrams SL, Ligresti G, Misaghian N, Wong EW, Steelman LS, Bäsecke J, Troppmair J, Libra M, Nicoletti F, et al: Involvement of p53 and Raf/MEK/ERK pathways in hematopoietic drug resistance. Leukemia. 22:2080–2090. 2008. View Article : Google Scholar : PubMed/NCBI